HALO Precision Diagnostics

HALO Precision Diagnostics is a leader in early disease detection using precision diagnostics. The company combines advanced imaging with molecular diagnostics to provide comprehensive clinical insights for early disease detection, effectively guiding diagnosis and treatment for both patients and physicians. With clinically validated care pathways dedicated to prostate cancer, breast cancer, cardiovascular, and neurodegenerative diseases, HALO is increasing early disease detection and transforming lives. HALO currently serves one million patients, and this number is expected to triple by 2024.